IP Library Granted Patent US 9,493,779
Granted Patent B2
US 9,493,779 · App. 14/019,293 · Granted Nov 15, 2016

FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks

Inventors: William Michael Ainley (Carmel, IN); Steven R. Webb (Westfield, IN); Pon Samuel (Carmel, IN); Dmitry Y. Guschin (Richmond, CA); Jeffrey C. Miller (Richmond, CA); Lei Zhang (Richmond, CA)
Assignees: Dow AgroSciences LLC; Sangamo BioSciences, Inc.
C12N15/822C12N9/22C12N15/102C12N15/66C12N15/8247C12N15/902
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,493,779
App. No.
14/019,293
Granted
Nov 15, 2016
Kind
B2
Abstract

Methods and compositions for gene disruption, gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a soybean cell, to generate a break in the FAD2 gene and then optionally integrating into the break a nucleic acid molecule of interest is disclosed.

Claims (34)

1. A method for integrating a nucleic acid sequence of interest into a specific site in the genome of a soybean cell, the method comprising:

cleaving, in a site specific manner, a target site within any of SEQ ID NOs:14 to 20 in a FAD2 gene in a soybean cell, to thereby generate a break in the FAD2 gene;

integrating into the break an exogenous nucleic acid sequence of interest.

2. The method according to claim 1 , wherein the FAD2 gene is a FAD2 2.3, FAD2 2.6 gene, or both.

3. The method according to claim 1 , wherein the cleaving in a site specific manner comprises introducing a fusion protein comprising a DNA-binding domain and a cleavage domain or cleavage half-domain into the cell, wherein the fusion protein binds with specificity to the target site and cleaves at or near the target site to thereby generate the break.

4. The method according to claim 3 , wherein the DNA-binding domain is selected from the group consisting of a meganuclease DNA-binding domain, a leucine zipper DNA-binding domain, a transcription activator-like (TAL) DNA-binding domain, a RNA-guided CRISPR-Cas9, a recombinase, a zinc finger protein DNA-binding domain, and chimeric combinations of any of the foregoing.

5. The method according to claim 3 , wherein the cleavage domain or cleavage half-domain is selected from the group consisting of a cleavage half-domain from a type IIS restriction endonuclease, a cleavage half-domain from FokI endonuclease, a cleavage half-domain from StsI endonuclease, and a homing endonuclease.

6. The method according to claim 3 , wherein the fusion protein is a zinc finger nuclease.

7. The method according to claim 6 , wherein the zinc finger nuclease comprises from three to six zinc finger domains, each zinc finger domain comprising a recognition helix region, wherein the zinc finger protein comprises the recognition helix regions ordered and shown in a single row of Table 2.

8. The method according to claim 2 , wherein the cleaving in a site specific manner is specific for some but not all copies of FAD2 2.3 and FAD2 2.6.

9. A soybean plant comprising a soybean cell modified by the following method:

cleaving, in a site specific manner, a target site in a FAD2 gene in a soybean cell, to generate one double-stranded break within any of SEQ ID NOs:14 to 20 in the FAD2 gene; and

integrating into the break an exogenous nucleic acid sequence of interest.

10. The plant according to claim 9 , wherein integrating into the break the nucleic acid sequence of interest does not have an adverse impact on the agronomic or quality properties of the plant.

11. The method according to claim 1 , wherein the break is a double-strand break.

12. The method according to claim 1 , wherein the nucleic acid sequence of interest is heterologous to the cell.

13. The method according to claim 1 , wherein the nucleic acid sequence of interest encodes a protein.

14. The method according to claim 1 , wherein the nucleic acid sequence of interest comprises a DNA-binding domain binding site.

15. The method according to claim 13 , wherein the nucleic acid sequence of interest is selected from the group consisting of insecticidal resistance genes, herbicide tolerance genes, nitrogen use efficiency genes, water use efficiency genes, nutritional quality genes, DNA binding genes, and selectable marker genes.

16. The method according to claim 3 , wherein the fusion protein is introduced into the cell as a polynucleotide encoding the fusion protein.

17. A transgenic soybean cell comprising an exogenous nucleotide sequence of interest integrated within any of SEQ ID NOs:14 to 20 of a FAD2 2.3 and/or FAD2 2.6 gene.

18. The transgenic cell of claim 17 , wherein the nucleotide sequence is heterologous to the cell.

19. The transgenic cell of claim 17 , wherein the nucleotide sequence is integrated into some but not all copies of the FAD2 2.3 and/or FAD2 2.6 gene.

20. A transgenic soybean plant or seed, comprising the transgenic cell of claim 17 .

21. The transgenic plant of claim 20 , wherein presence of the nucleotide sequence in the FAD2 2.3 and FAD2 2.6 gene does not have an adverse impact on the agronomic or quality properties of the plant.

22. A method of cleaving a FAD2 loci in a soybean cell, the method comprising:

introducing a fusion protein comprising a DNA-binding domain and a cleavage domain or cleavage half-domain into the cell, wherein the fusion protein binds with specificity to a target site within any of SEQ ID NOs:14 to 20 in the FAD2 loci and cleaves to generate a break.

23. The method according to claim 22 , further comprising integrating into the break a nucleic acid molecule of interest.

24. The method according to claim 22 , wherein the FAD2 loci is a FAD2 2.3 gene, FAD2 2.6 gene, or both.

25. The method according to claim 22 , wherein the DNA-binding domain is selected from the group consisting of a meganuclease DNA-binding domain, a leucine zipper DNA-binding domain, a transcription activator-like (TAL) DNA-binding domain, a RNA-guided CRISPR-Cas9, a recombinase, a zinc finger protein DNA-binding domain, and chimeric combinations of any of the foregoing.

26. The method according to claim 22 , wherein the cleavage domain or cleavage half-domain is selected from the group consisting of a cleavage half-domain from a type IIS restriction endonuclease, a cleavage half-domain from FokI endonuclease, a cleavage half-domain from StsI endonuclease, and a homing endonuclease.

27. The method according to claim 22 , wherein the fusion protein is a zinc finger nuclease.

28. The method according to claim 27 , wherein the zinc finger nuclease comprises five or six zinc finger domains ordered finger 1 to finger 5 or finger 1 to finger 6, each zinc finger domain comprising a recognition helix region, wherein the zinc finger protein comprises the recognition helix regions ordered and shown in a single row of Table 2.

29. The method according to claim 22 , wherein the cleaving is specific for some but not all copies FAD2 2.3 and FAD2 2.6.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2019
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 048444/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2014
From: AINLEY, W. MICHAEL; WEBB, STEVEN R; SAMUEL, JAYAKUMAR P
To: DOW AGROSCIENCES LLC
Reel/Frame 032824/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2014
From: GUSCHIN, DMITRY Y.; MILLER, JEFFREY C.; ZHANG, LEI
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 032740/0046 →
Continuity (2)
Provisional Application 61697886 · Sep 7, 2012
Related Publication 20140090116A1 · Mar 27, 2014